Revive Therapeutics Ltd. RVV.CN · Stock Open Revive Therapeutics Ltd. in new tab
Revive Therapeutics Ltd. Analysis (RVV.CN)
Is Revive Therapeutics Ltd. a good investment? Revive Therapeutics Ltd. (RVV.CN) is currently trading at 0.0300 CAD.
Investor FAQ
Does Revive Therapeutics Ltd. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Revive Therapeutics Ltd.?
Revive Therapeutics Ltd. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
Company Profile
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.
| Split Date | Split Ratio to 1 |
|---|---|
| Jan. 25, 2017 | 1.27 |
Community Discussion